Mylan Pharmaceuticals Inc. 401(K) Defined Contribution Plan — Form 5500 plan (Mylan Pharmaceuticals Inc.)
Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Mylan Pharmaceuticals Inc. 401(K) Defined Contribution Plan is a benefit plan reported by Mylan Pharmaceuticals Inc. under EIN 55-0455423 and plan number 005. The latest loaded filing year is 2023. The filing reports 634 participants and $44,288,456 in end-of-year plan assets, where available in the loaded dataset.
Key reported metrics
- Plan sponsor
- Mylan Pharmaceuticals Inc.
- EIN
- 55-0455423
- Plan number
- 005
- Plan type
- 2
- Location
- Canonsburg, PA
- Latest filing year
- 2023
- Participants
- 634
- End-of-year plan assets
- $44,288,456
Form 5500 filing history
| Filing year | Participants | Schedules | Filing |
|---|---|---|---|
| 2023 | 634 | H, C | 20241011130500NAL0021908401001 |
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $44,288,456
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $44,288,456
- Net assets (BOY)
- $48,480,782
Income & contributions
- Employer contributions
- $29,232
- Participant contributions
- $25,919
- Total contributions
- $55,151
- Total income / additions
- $4,706,428
Expenses & distributions
- Benefits paid
- $8,897,529
- Administrative expenses
- $1,225
- Total expenses
- $8,898,754
- Net increase / (decrease)
- -$4,192,326
Service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. | Year |
|---|---|---|---|---|
| Merrill Lynch, Pierce, Fenner And S | RECORDKEEPER | $1,225 | $0 | 2023 |